| |
| |
|
| Insider
Information: |
Gorman Kevin Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
517,112 |
|
|
Indirect Shares
|
57,996 |
|
|
| Direct
Value |
$71,519,380 |
|
|
|
Indirect Value
|
$8,086,382 |
|
|
| Total
Shares |
575,108 |
|
|
| Total
Value |
$79,605,763 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 17.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Executive Office... |
2024-02-13 |
512,052 |
2004-09-22 |
57,996 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2024-02-13 |
5,060 |
2023-06-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
82 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-06 |
4 |
AS |
$105.68 |
$321,259 |
D/D |
(3,040) |
468,008 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-07 |
4 |
AS |
$102.30 |
$2,430,315 |
D/D |
(23,730) |
489,322 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-02-08 |
4 |
AS |
$104.30 |
$237,185 |
D/D |
(2,274) |
491,365 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2023-08-21 |
4 |
AS |
$107.40 |
$1,001,816 |
D/D |
(9,328) |
499,754 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-08 |
4 |
AS |
$132.44 |
$14,016,523 |
D/D |
(105,835) |
499,754 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-09 |
4 |
AS |
$134.01 |
$8,311,895 |
D/D |
(62,023) |
499,754 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-01-31 |
4 |
AS |
$140.69 |
$380,845 |
D/D |
(2,707) |
502,188 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-06 |
4 |
AS |
$142.18 |
$432,218 |
D/D |
(3,040) |
504,919 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-08 |
4 |
AS |
$134.15 |
$305,052 |
D/D |
(2,274) |
506,962 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2024-02-13 |
4 |
AS |
$133.02 |
$376,700 |
D/D |
(2,832) |
514,596 |
0 |
% |
|
| XNCR |
Xencor Inc |
Director |
• • – |
2024-02-13 |
4 |
B |
$19.12 |
$1,013 |
D/D |
53 |
5,060 |
2.31 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Vice President Business Dev. |
• – – |
2004-09-22 |
4 |
D |
$55.19 |
$100,059 |
I/I |
(1,813) |
57,996 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2018-02-06 |
4 |
D |
$82.48 |
$337,426 |
D/D |
(4,091) |
347,033 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
PRESIDENT AND CEO |
• • – |
2014-12-18 |
4 |
OE |
$2.59 |
$295,150 |
D/D |
70,000 |
195,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2015-01-08 |
4 |
OE |
$2.59 |
$64,750 |
D/D |
25,000 |
205,952 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2015-03-24 |
4 |
OE |
$2.59 |
$103,600 |
D/D |
40,000 |
228,452 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
President and CEO |
• • – |
2016-12-23 |
4 |
OE |
$2.59 |
$23,569 |
D/D |
9,100 |
237,177 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-02-08 |
4 |
OE |
$2.59 |
$166,177 |
D/D |
64,161 |
314,703 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2017-05-02 |
4 |
OE |
$2.59 |
$56,304 |
D/D |
21,739 |
354,346 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2018-02-06 |
4 |
OE |
$5.76 |
$576,000 |
D/D |
100,000 |
442,874 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2018-05-01 |
4 |
OE |
$5.76 |
$730,552 |
D/D |
126,832 |
473,865 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2018-06-28 |
4 |
OE |
$5.76 |
$533,416 |
D/D |
57,924 |
404,957 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-06 |
4 |
OE |
$8.66 |
$440,889 |
D/D |
50,911 |
468,508 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-07 |
4 |
OE |
$8.66 |
$23,893 |
D/D |
2,759 |
420,356 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Executive Officer |
• • – |
2019-08-08 |
4 |
OE |
$8.66 |
$228,018 |
D/D |
26,330 |
443,927 |
0 |
- |
|
82 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
